Wardwizard Healt

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE048E01013
  • NSEID:
  • BSEID: 512063
INR
43.19
0.00 (0.00%)
BSENSE

May 07

BSE+NSE Vol: 50

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

50 (400.00%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

74.08%

When is the next results date for Wardwizard Healt?

23-May-2025

No Upcoming Board Meetings

Who are the peers of the Wardwizard Healt?

16-Jul-2025

Wardwizard Healt's peers include Filtron Engineer, Revati Organics, Gold Rock Inves., Hind Commerce, Alna Trading, Kusam Electr., Pervasive Comm., Classic Electric, and Springform Tech. While Gold Rock Inves. has the highest 1-year return at 33.60%, Wardwizard Healt outperforms with a return of 54.89%.

Peers: The peers of Wardwizard Healt are Filtron Engineer, Revati Organics, Gold Rock Inves., Hind Commerce, Alna Trading, Kusam Electr., Pervasive Comm., Classic Electric, and Springform Tech.<BR><BR>Quality Snapshot: Filtron Engineer does not qualify in terms of management risk, growth, and capital structure. Similarly, Revati Organics, Gold Rock Inves., Hind Commerce, Alna Trading, Kusam Electr., Pervasive Comm., Classic Electric, and Springform Tech also do not qualify in these areas, indicating that they all share a similar level of risk and growth potential, and the rest.<BR><BR>Return Snapshot: Gold Rock Inves. has the highest 1-year return at 33.60%, while Hind Commerce has the lowest at 0.00%. Wardwizard Healt's 1-year return of 54.89% is significantly higher than both of these peers. Additionally, all peers except Gold Rock Inves. have a six-month return of 0.00%, indicating no growth in that period.

View full answer

Who are in the management team of Wardwizard Healt?

16-Jul-2025

As of March 2021, the management team of Wardwizard Healt includes Joydeep Mazumder (Managing Director), Gouranga Lal Kundu (Company Secretary), and several directors, including independent and additional directors, contributing to the company's governance.

As of March 2021, the management team of Wardwizard Healt includes the following individuals:<BR><BR>1. Gouranga Lal Kundu - Company Secretary<BR>2. Joydeep Mazumder - Managing Director<BR>3. Ankita Chanda - Additional Independent Director<BR>4. Souvik Bose - Independent Director<BR>5. Munmun Mandal - Director<BR>6. Adipta Majumder - Additional Independent Director<BR>7. Subhendu Saha - Additional Director<BR>8. Dipankar Majumder - Independent Director<BR>9. Dharmesh Chauhan - Company Secretary & Compliance Officer<BR><BR>Each member holds a specific designation within the company, contributing to its governance and management.

View full answer

What does Wardwizard Healt do?

17-Jul-2025

Wardwizard Healthcare Ltd, a Micro Cap company in the Trading & Distributors industry, was incorporated in 1985 and reported net sales of 1 Cr and a net loss of 11 Cr for the quarter ending March 2025. The company has a market cap of 1 Cr and no dividends or debt.

Overview:<BR>Wardwizard Healthcare Ltd operates in the Trading & Distributors industry and is classified as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in 1985 as 'Ayoki Merchantile Limited' and changed its name to 'Wardwizard Healthcare Limited' on December 11, 2023. The most recent quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -11 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 1 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: Laxmi Commercial Centre 4th Fr, Room No 405 S B Marg Dadar(W) Mumbai Maharashtra : 400028 <BR>Tel: 91-22-24219195/32435510 <BR>Email: ayokimerchantile@gmail.com <BR>Website: http://www.ayokimerchantile.com

View full answer

Who are the top shareholders of the Wardwizard Healt?

17-Jul-2025

The top shareholder of Wardwizard Healt is Yatin Sanjay Gupte, holding 37.04%, with no pledged promoter holdings. The highest public shareholder is Shiva Avdheshratan Dubey at 5.35%, and individual investors collectively own 18.52% of the shares.

The top shareholders of Wardwizard Healt include the promoters, with Yatin Sanjay Gupte holding the largest share at 37.04%. There are no pledged promoter holdings, and the company currently has no mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Shiva Avdheshratan Dubey, who owns 5.35%. Additionally, individual investors collectively hold 18.52% of the company's shares.

View full answer

How has been the historical performance of Wardwizard Healt?

11-Aug-2025

Wardwizard Healt has consistently reported no profit or cash flow from 2018 to 2024, with profit before tax and cash flow remaining at 0.00 Rs cr for multiple years, indicating stagnant financial performance.

Answer:<BR>The historical performance of Wardwizard Healt shows a consistent lack of profit and cash flow across multiple years.<BR><BR>Breakdown:<BR>Wardwizard Healt has reported a profit before tax of 0.00 Rs cr for the years ending March 2024, 2023, 2022, 2020, 2019, and 2018, indicating no profitability during this period. Adjustments and changes in working capital also remained at 0.00 Rs cr for the same years, with a minor adjustment of -0.01 Rs cr in March 2018 and a slight increase of 0.01 Rs cr in working capital in the same year. Cash flow after changes in working capital was consistently 0.00 Rs cr from March 2024 to March 2022, with a small positive cash flow of 0.01 Rs cr in March 2018. Cash flow from operating and investing activities remained at 0.00 Rs cr for the years ending March 2024 to March 2022, while there was a cash inflow of 0.07 Rs cr from investing activities in March 2018. The net cash inflow/outflow was also 0.00 Rs cr for the years 2024 to 2022, with a closing cash and cash equivalent of 0.00 Rs cr in March 2024, 2023, and 2022, and a slight increase to 0.10 Rs cr in March 2018. Overall, the data reflects a stagnant financial performance with no significant changes in cash flow or profitability over the years.

View full answer

Why is Wardwizard Healthcare Ltd falling/rising?

07-May-2026

As of 06-May, the stock price of Wardwizard Healthcare Ltd is Rs. 43.19, showing stability but indicating a positive trend due to a new all-time high, strong opening gains, and consistent performance above key moving averages. Despite some volatility, overall indicators suggest a bullish outlook for the stock.

As of 06-May, the stock price of Wardwizard Healthcare Ltd is currently at Rs. 43.19, showing no change (0.00%). Despite this stability in price, several factors indicate a positive trend for the stock. <BR><BR>Today, the stock reached a new 52-week and all-time high of Rs. 43.19, which reflects strong performance. It opened with a gain of 4.98%, suggesting positive market sentiment at the start of the trading day. Furthermore, the stock has outperformed its sector by 4.88%, indicating that it is performing better than many of its peers.<BR><BR>In terms of trading patterns, Wardwizard Healthcare Ltd has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is typically a bullish sign. This consistent performance above these averages suggests that the stock is in a strong upward trend over various time frames.<BR><BR>However, it is important to note that the stock has experienced erratic trading, having not traded on 5 out of the last 20 days. This could imply some volatility, but the overall indicators point towards a positive outlook for the stock. <BR><BR>In summary, while the stock price remains unchanged today, the achievement of a new high, strong opening performance, and favorable moving averages suggest that Wardwizard Healthcare Ltd is on a rising trajectory.

View full answer

Which are the latest news on Wardwizard Healt?

07-May-2026
No latest news for Wardwizard Healt found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Trading & Distributors

stock-summary
Market cap

INR 1 Cr (Micro Cap)

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Dec 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
10.21%
0%
10.21%
1 Year
117.69%
0%
117.69%
2 Years
139.94%
0%
139.94%
3 Years
139.94%
0%
139.94%
4 Years
139.94%
0%
139.94%
5 Years
0%
0%
0.0%

Wardwizard Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

29-Apr-2026 | Source : BSE

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Wardwizard Healthcare Ltd
2 CIN NO. L20237MH1985PLC034972
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 2025-2026 and 2026-2027
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)2024-2025 and 2025-2026
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-RAJBALA KIRORIWAL
Designation :-COMAPNY SECRETARY AND COMPLIANCE OFFICER
Name of the Chief Financial Officer :- NA
Designation : -NA

Date: 29/04/2026

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

29-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyWardwizard Healthcare Ltd
2CIN NO.L20237MH1985PLC034972
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.67
4Highest Credit Rating during the previous FY 0
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: RAJBALA KIRORIWAL
Designation: COMPANY SECRETATRY AND COMPLIANCE OFFICER
EmailId: ayoki1985@gmail.com
Name of the Chief Financial Officer: NA
Designation: NA
EmailId: ayokiacc@gmail.com

Date: 29/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Shareholder Meeting / Postal Ballot-Scrutinizers Report

28-Apr-2026 | Source : BSE

Attached herewith Voting Results of Postal Ballot of Wardwizard Healthcare Limited

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

No Data Found

Valuation key factors

No Data Found

Technicals key factors

Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Yatin Sanjay Gupte (37.04%)

Highest Public shareholder

Shikesh Ventures Private Limited (4.9%)

Individual Investors Holdings

18.46%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -11.11% vs 0.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 76.32% vs -261.90% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.08",
          "val2": "0.09",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.24",
          "val2": "-0.63",
          "chgp": "61.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.18",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.18",
          "val2": "-0.76",
          "chgp": "76.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-300.00%",
          "val2": "-700.00%",
          "chgp": "400.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -13.64% vs 100.00% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 44.05% vs -1,100.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.19",
          "val2": "0.22",
          "chgp": "-13.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.70",
          "val2": "-0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.07",
          "val2": "0.19",
          "chgp": "-63.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.47",
          "val2": "-0.84",
          "chgp": "44.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-368.42%",
          "val2": "-318.18%",
          "chgp": "-50.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -12.90% vs 181.82% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 59.38% vs -471.43% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.27",
          "val2": "0.31",
          "chgp": "-12.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.94",
          "val2": "-1.33",
          "chgp": "29.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.07",
          "val2": "0.37",
          "chgp": "-81.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.65",
          "val2": "-1.60",
          "chgp": "59.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-348.15%",
          "val2": "-429.03%",
          "chgp": "80.88%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 281.82% vs -21.43% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -502.22% vs -1,400.00% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.42",
          "val2": "0.11",
          "chgp": "281.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.33",
          "val2": "-0.34",
          "chgp": "-585.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.55",
          "val2": "0.03",
          "chgp": "1,733.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-2.71",
          "val2": "-0.45",
          "chgp": "-502.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-554.76%",
          "val2": "-309.09%",
          "chgp": "-245.67%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
0.08
0.09
-11.11%
Operating Profit (PBDIT) excl Other Income
-0.24
-0.63
61.90%
Interest
0.00
0.18
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.18
-0.76
76.32%
Operating Profit Margin (Excl OI)
-300.00%
-700.00%
400.00%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is -11.11% vs 0.00% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is 76.32% vs -261.90% in Dec 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
0.19
0.22
-13.64%
Operating Profit (PBDIT) excl Other Income
-0.70
-0.70
Interest
0.07
0.19
-63.16%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.47
-0.84
44.05%
Operating Profit Margin (Excl OI)
-368.42%
-318.18%
-50.24%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -13.64% vs 100.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 44.05% vs -1,100.00% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
0.27
0.31
-12.90%
Operating Profit (PBDIT) excl Other Income
-0.94
-1.33
29.32%
Interest
0.07
0.37
-81.08%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.65
-1.60
59.38%
Operating Profit Margin (Excl OI)
-348.15%
-429.03%
80.88%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -12.90% vs 181.82% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 59.38% vs -471.43% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
0.42
0.11
281.82%
Operating Profit (PBDIT) excl Other Income
-2.33
-0.34
-585.29%
Interest
0.55
0.03
1,733.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
-2.71
-0.45
-502.22%
Operating Profit Margin (Excl OI)
-554.76%
-309.09%
-245.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 281.82% vs -21.43% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -502.22% vs -1,400.00% in Mar 2024

stock-summaryCompany CV
About Wardwizard Healthcare Ltd stock-summary
stock-summary
Wardwizard Healthcare Ltd
Micro Cap
Trading & Distributors
Wardwizard Healthcare Limited was erstwhile incorporated as 'Ayoki Merchantile Limited' on January 3, 1985. The Company name was changed from 'Ayoki Merchantile Limited' to 'Wardwizard Healthcare Limited' on December 11, 2023. Initially, the Company engaged in the Business of trading in Consumer Goods and Services, providing Advisory, Consultancy, Investments Services.
Company Coordinates stock-summary
Company Details
Laxmi Commercial Centre 4th Fr, Room No 405 S B Marg Dadar(W) Mumbai Maharashtra : 400028
stock-summary
Tel: 91-22-24219195/32435510
stock-summary
ayokimerchantile@gmail.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai